Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new products.
Medical Devices
FDA approves Abbott’s Volt PFA system for atrial fibrillation
Neurable secures $35m to expedite BCI technology commercialisation
ZOLL introduces next-gen wearable cardioverter defibrillator in US
Curasight doses first patient in Phase I brain cancer trial of uTREAT
Abbott secures FDA and CE Mark approvals for Amplatzer delivery system
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea
